**Author details**

Giorgia Centonze1†, Jennifer Chapelle1†, Costanza Angelini1†, Dora Natalini1†, Davide Cangelosi<sup>2</sup> , Vincenzo Salemme1 , Alessandro Morellato1 , Emilia Turco1 and Paola Defilippi1 \*

1 Department of Molecular Biotechnology and Health Science, University of Torino, Torino, Italy

2 Laboratory of Molecular Biology, Giannina Gaslini Institute, Genova, Italy

\*Address all correspondence to: paola.defilippi@unito.it

† These authors equally contribute to this work.

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**93**

p. 289-97.

*The Scaffold Protein p140Cap as a Molecular Hub for Limiting Cancer Progression…*

*Functional Synapses in the Neocortex.* Neuron, 2017. **94**(6): p. 1155-1172 e8.

[11] Ogawa, S., et al., *Oncogenic mutations of ALK in neuroblastoma.* Cancer Sci, 2011. **102**(2): p. 302-8.

[12] Zhu, S., et al., *Activated ALK* 

[13] Wang, L.L., et al., *Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study.* Br J Cancer, 2015. **113**(1):

[14] Nakagawara, A., et al., *Expression and function of TRK-B and BDNF in human neuroblastomas.* Mol Cell Biol,

[15] Diskin, S.J., et al., *Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.* Nat Genet, 2012. **44**(10): p. 1126-30.

[16] van Limpt, V., et al., *The Phox2B homeobox gene is mutated in sporadic neuroblastomas.* Oncogene, 2004. **23**(57):

[18] Morgenstern, D.A., S. Baruchel, and M.S. Irwin, *Current and future strategies for relapsed neuroblastoma: challenges on the road to precision therapy.* J Pediatr Hematol Oncol, 2013. **35**(5):

[19] Whittle, S.B., et al., *Overview and recent advances in the treatment of neuroblastoma.* Expert Rev Anticancer

Ther, 2017. **17**(4): p. 369-386.

[17] Owens, C. and M. Irwin, *Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.* Crit Rev Clin Lab Sci, 2012.

p. 362-73.

p. 57-63.

p. 9280-8.

**49**(3): p. 85-115.

p. 337-47.

1994. **14**(1): p. 759-67.

*collaborates with MYCN in neuroblastoma pathogenesis.* Cancer Cell, 2012. **21**(3):

*DOI: http://dx.doi.org/10.5772/intechopen.96383*

[1] Gatta, G., et al., *Embryonal cancers in Europe.* Eur J Cancer, 2012. **48**(10): p.

[2] Maris, J.M., *Recent advances in neuroblastoma.* N Engl J Med, 2010.

[3] Farrell, P.A., A.L. Caston, and D. Rodd, *Changes in insulin response to glucose after exercise training in partially pancreatectomized rats.* J Appl Physiol (1985), 1991. **70**(4): p. 1563-8.

[4] DuBois, S.G., et al., *Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.* J Pediatr Hematol Oncol, 1999. **21**(3):

[5] Brodeur, G.M. and R. Bagatell, *Mechanisms of neuroblastoma regression.* Nat Rev Clin Oncol, 2014. **11**(12):

[6] Brodeur, G.M., et al., *Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.* J Clin Oncol, 1993. **11**(8): p.

[7] Monclair, T., et al., *The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.* J Clin Oncol, 2009. **27**(2): p. 298-303.

[8] Schleiermacher, G., et al., *Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.* Br J Cancer, 2012.

[9] Cohn, S.L., et al., *The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.* J Clin Oncol, 2009. **27**(2):

[10] Li, M.Y., et al., *A Critical Role of Presynaptic Cadherin/Catenin/p140Cap Complexes in Stabilizing Spines and* 

**362**(23): p. 2202-11.

**References**

1425-33.

p. 181-9.

p. 704-13.

1466-77.

**107**(8): p. 1418-22.

*The Scaffold Protein p140Cap as a Molecular Hub for Limiting Cancer Progression… DOI: http://dx.doi.org/10.5772/intechopen.96383*
